saikosaponin d has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Gao, M; Jiang, H; Li, H; Ye, C; Yu, K | 1 |
| Gu, J; Jiang, D; Liu, L; Qin, M; Wang, P; Xing, Y; Xu, H; Yang, H; Yang, R | 1 |
| Lai, Y; Zhu, Y | 1 |
| Gurav, NS; Gurav, SS; Prasad, RS; Prasad, SK; Shakya, A; Singh, S; Sinha, SK | 1 |
| Bahbah, EI; Nabet, MS; Negida, A | 1 |
1 review(s) available for saikosaponin d and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pharmacological properties and derivatives of saikosaponins-a review of recent studies.
Topics: Anti-Inflammatory Agents; Antiviral Agents; COVID-19; Humans; Oleanolic Acid; Saponins; SARS-CoV-2 | 2023 |
4 other study(ies) available for saikosaponin d and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study.
Topics: Amino Acid Motifs; Binding Sites; Cell Adhesion Molecules; Computer Simulation; COVID-19; Cytokines; Epitopes; Flavanones; Glucosides; Glycosides; Humans; Lectins, C-Type; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Oleanolic Acid; Polysaccharides; Receptors, Cell Surface; Saponins; Spike Glycoprotein, Coronavirus | 2021 |
Identification of Potential TMPRSS2 Inhibitors for COVID-19 Treatment in Chinese Medicine by Computational Approaches and Surface Plasmon Resonance Technology.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Medicine, Chinese Traditional; Molecular Docking Simulation; Molecular Dynamics Simulation; Rutin; Serine Endopeptidases; Serine Proteinase Inhibitors; Surface Plasmon Resonance | 2023 |
An
Topics: COVID-19; Glycoproteins; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Oleanolic Acid; Saponins; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Purposing Saikosaponins for the treatment of COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Lymphocyte Activation; Molecular Docking Simulation; Oleanolic Acid; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Saponins; SARS-CoV-2 | 2020 |